MIXED VACCINE AGAINST ANAEROBIC ENTEROTOXEMIA AND ESCHERICHIOSIS IN PIGLETS

FIELD: veterinary science, microbiology, vaccines, biotechnology. SUBSTANCE: mixed vaccine has a clostridious component as Clostridium perfringens N 3 producing B-toxin of type C actively. It has a complex escherichiosis component consisting of a set of polysaccharide antigens O, K, adhesive antigen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIRILLOV L.V, MALAKHOV JU.A, STOROZHEV L.I, SEMENOV L.V, PIROZHKOV M.K, MEN'SHENIN V.V, SUSSKIJ E.V, TUGARINOV O.A
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: veterinary science, microbiology, vaccines, biotechnology. SUBSTANCE: mixed vaccine has a clostridious component as Clostridium perfringens N 3 producing B-toxin of type C actively. It has a complex escherichiosis component consisting of a set of polysaccharide antigens O, K, adhesive antigens, TL- and TC-anatoxins taken at the ratio 1:1. Vaccine provides broad pattern of immunogenetics against enterotoxemia and escherichiosis in piglets at two-fold vaccination of pregnant pigs. The use of the mixed vaccine decreases labor intensity by two-fold, injection numbers and time required for vaccination as compared with the use of monovaccine. EFFECT: enhanced effectiveness. 1 tbl, 3 ex